Skip to search formSkip to main contentSkip to account menu

Razupenem

Known as: (4R,5S,6S)-6-((1r)-1-Hydroxyethyl)-4-Methyl-3-((4-((5S)-5-Methyl-2,5-Dihydro-1H-Pyrrol-3-yl)Thiazol-2-yl)Sulfanyl)-7-Oxo-1-Azabicyclo(3.2.0)Hept-2-Ene-2-Carboxylic Acid 
A broad-spectrum carbapenem with activity against gram-positive bacteria, including methicillin-resistant S. aureus.
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

SM-216601

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Looking for the new preparations for antibacterial therapy. II. Clinical trials; new beta-lactam antibiotics and beta-lactamase inhibitors.
To obtain a status of a medicinal product, a compound possessing potential antimicrobial activity and displaying no cytotoxicity… 
2011
2011
Pharmacodynamics of Razupenem (PZ601) Studied in an In Vitro Pharmacokinetic Model of Infection
ABSTRACT Simulations of administration of razupenem at 1 g every 12 h by 1-h intravenous (i.v.) infusion were performed in an in… 
2011
2011
In Vitro Antimicrobial Activity of Razupenem (SMP-601, PTZ601) against Anaerobic Bacteria
ABSTRACT We evaluated the in vitro antianaerobic activity of razupenem (SMP-601, PTZ601), a new parenterally administered… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)